STING1 and cancer: Our recent studies showed that topotecan, a TOP1 inhibitor, binds to ribosomal protein RPL15, resulting in the induction of ribosomal stress and the secretion of DNA-containing exosomes as DAMPs from cancer cells, which activate STING-dependent antitumor immune responses [21, 22].